Your browser doesn't support javascript.
loading
Identification and Characterization of Novel Founder Mutations in NDRG1: Refining the Genetic Landscape of Charcot-Marie-Tooth Disease Type 4D in Bulgaria.
Atkinson, Derek; Chamova, Teodora; Candayan, Ayse; Kastreva, Kristina; Asenov, Ognian; Litvinenko, Ivan; Estrada-Cuzcano, Alejandro; De Vriendt, Els; Kukushev, Georgi; Tournev, Ivailo; Jordanova, Albena.
Afiliación
  • Atkinson D; Molecular Neurogenomics Group, VIB Center for Molecular Neurology, VIB, 2610 Antwerp, Belgium.
  • Chamova T; Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.
  • Candayan A; Department of Neurology, Medical University-Sofia, 1431 Sofia, Bulgaria.
  • Kastreva K; Molecular Neurogenomics Group, VIB Center for Molecular Neurology, VIB, 2610 Antwerp, Belgium.
  • Asenov O; Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.
  • Litvinenko I; Department of Neurology, Medical University-Sofia, 1431 Sofia, Bulgaria.
  • Estrada-Cuzcano A; Department of Neurology, Medical University-Sofia, 1431 Sofia, Bulgaria.
  • De Vriendt E; Department of Pediatrics, Medical University-Sofia, 1431 Sofia, Bulgaria.
  • Kukushev G; Molecular Neurogenomics Group, VIB Center for Molecular Neurology, VIB, 2610 Antwerp, Belgium.
  • Tournev I; Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.
  • Jordanova A; Molecular Neurogenomics Group, VIB Center for Molecular Neurology, VIB, 2610 Antwerp, Belgium.
Int J Mol Sci ; 25(16)2024 Aug 21.
Article en En | MEDLINE | ID: mdl-39201732
ABSTRACT
Charcot-Marie-Tooth neuropathy type 4D (CMT4D) is a rare genetic disorder of the peripheral nervous system caused by biallelic mutations in the N-Myc Downstream Regulated 1 gene (NDRG1). Patients present with an early onset demyelinating peripheral neuropathy causing severe distal muscle weakness and sensory loss, leading to loss of ambulation and progressive sensorineural hearing loss. The disorder was initially described in the Roma community due to a common founder mutation, and only a handful of disease-causing variants have been described in this gene so far. Here, we present genetic and clinical findings from a large Bulgarian cohort of demyelinating CMT patients harboring recurrent and novel variants in the NDRG1 gene. Notably, two splice-site variants are exclusive to Bulgarian Muslims and reside in ancestral haplotypes, suggesting a founder effect. Functional characterization of these novel variants implicates a loss-of-function mechanism due to shorter gene products. Our findings contribute to a deeper understanding of the genetic and clinical heterogeneity of CMT4D and highlight novel founder mutations in the ethnic minority of Bulgarian Muslims.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Charcot-Marie-Tooth / Efecto Fundador / Proteínas de Ciclo Celular / Péptidos y Proteínas de Señalización Intracelular Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Charcot-Marie-Tooth / Efecto Fundador / Proteínas de Ciclo Celular / Péptidos y Proteínas de Señalización Intracelular Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Suiza